Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials
Journal article published in 2015 by
M. J. Sorich,
M. D. Wiese,
A. Rowland,
G. Kichenadasse,
R. A. McKinnon 
,
C. S. Karapetis
,
C. S. Karapetis
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 